Protagenic Therapeutics, Inc.\new Loans Payable, Current
Protagenic Therapeutics, Inc.\new (PTIX) had Loans Payable, Current of $840.39 thousand as of 2025-12-31, per its 10-Q filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2026-08-14
- 2025-12-31: Loans Payable, Current $840.39K.
- 2025-09-30: Loans Payable, Current $841.55K.
- 2025-03-31: Loans Payable, Current $779.20K.
| Period end | Loans Payable, Current |
|---|---|
| 2025-12-31 | $840.39K 10-Q · filed 2026-03-09 |
| 2025-09-30 | $841.55K 10-Q · filed 2025-11-26 |
| 2025-03-31 | $779.20K 10-K · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |